Literature DB >> 1557839

Current perspectives on diagnosis and treatment of superficial bladder cancer.

D L Lamm1, G Griffith, L L Pettit, U O Nseyo.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1557839     DOI: 10.1016/0090-4295(92)90202-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer.

Authors:  K Taniguchi; S Koga; M Nishikido; S Yamashita; T Sakuragi; H Kanetake; Y Saito
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  BCG in the treatment of superficial cancer of the bladder: a review.

Authors:  S Friberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

3.  Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder.

Authors:  L Moltó; J Carballido; L Manzano; E Reyes; C Olivier; M Alvarez-Mon
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  Biologic response modifiers in the management of superficial bladder cancer.

Authors:  S Serels; J Fleischmann
Journal:  World J Urol       Date:  1997       Impact factor: 3.661

5.  A Comparison Between ThinPrep Monolayer and Cytospin Cytology for the Detection of Bladder Cancer.

Authors:  Ji Yong Kim; Hyung Jin Kim
Journal:  Korean J Urol       Date:  2014-06-16

6.  Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.

Authors:  L Molto; M Alvarez-Mon; J Carballido; L Manzano; C Guillen; A Prieto; C Olivier; M Rodriguez-Zapata
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.